Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network RFA

Aligning Research to Impact Autism (ARIA) is opening a Request for Applications (RFA) for institution-based, collaborative, multidisciplinary clinical research teams to join the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, a robust and collaborative international network of sites with the goal to accelerate clinical trial readiness and implementation for both syndromic and non-syndromic forms of autism.

2Up Accordion Exmaple

Despite advancements in autism research, translating these discoveries into improved care and better outcomes for those with autism, profound autism, and related neurodevelopmental disorders (NDDs) remains a challenge.

1Up FAQ Example

Frequently Asked Questions

1Up Form Example

For inquiries about scientific priorities, eligibility requirements, and application submission, please contact grants@aligningscience.com

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

1Up Media Headline

Despite advancements in autism research, translating these discoveries into improved care and better outcomes for those with autism, profound autism, and related neurodevelopmental disorders (NDDs) remains a challenge.

Abstract Art Illustration

1Up Media Youtube Example

Despite advancements in autism research, translating these discoveries into improved care and better outcomes for those with autism, profound autism, and related neurodevelopmental disorders (NDDs) remains a challenge.

Abstract Art Illustration

1Up Media Vimeo Example

Despite advancements in autism research, translating these discoveries into improved care and better outcomes for those with autism, profound autism, and related neurodevelopmental disorders (NDDs) remains a challenge.

Abstract Art Illustration

1Up Media MP4 Example

Despite advancements in autism research, translating these discoveries into improved care and better outcomes for those with autism, profound autism, and related neurodevelopmental disorders (NDDs) remains a challenge.

Abstract Art Illustration

1Up Table Example

Despite advancements in autism research, translating these discoveries into improved care and better outcomes for those with autism, profound autism, and related neurodevelopmental disorders (NDDs) remains a challenge.

Deadline Date
Submission portal opens: June 2025
Pre-Application Submission Deadline: July 14, 2025
Select Applicants Invited to Submit Full Applications: August 11, 2025
Full Application Submission Deadline: October 13, 2025
External Review Period: October 20-November 24, 2025
Virtual Call with Applicants: December 8-15,2025
Anticipated Award Notification Date: December 19, 2025
Anticipated Funds Release: Q1-Q2 2026

About the IMPACT Network

Despite advancements in autism research, translating these discoveries into improved care and better outcomes for those with autism, profound autism, and related neurodevelopmental disorders (NDDs) remains a challenge. 

The ARIA IMPACT Network will be a pediatric clinical trials network focused within autism. Its goals are to:

  • Achieve clinical trial excellence by leveraging the latest scientific advancements and navigating rare disease and neurodevelopment-specific study barriers 
  • Drive research and innovation by translating discoveries into meaningful clinical outcomes while developing personalized care for autism
  • Cultivate collaboration and partnerships between key stakeholders, including regulatory agencies, biotechnology companies, industry partners, and nonprofit organizations
  • Develop a robust data infrastructure to ensure high-quality data collection and curation
  • Maintain alignment with ARIA’s strategic priorities

The IMPACT Network will comprise a multisite clinical trial infrastructure enabling rapid and effective therapeutic development. This network will serve as a foundation and catalyst for all types of therapeutics – from n-of-1 studies in syndromic autism, to large-scale pharmacological trials in non-syndromic autism, to early behavioral intervention trials.

Requirements & How To Apply

The Request for Application (RFA) process has four steps

  • An open pre-application
  • An invited full application
  • An external review
  • A finalist interview and presentation

Proposals will be accepted from any United States (including Territories of the United States), United Kingdom, and Canada-based public or private-sector organizations, including nonprofit and for-profit organizations, that provide clinical care for individuals affected by autism and related NDDs.

Applicants invited to submit a full application may request up to $9 million USD, which will be split across two phases: an operational ramp-up phase and a trial readiness phase.

The number of funded participating sites is flexible and is dependent on the applications received throughout the RFA period.

For a full list of all instructions and requirements, and to apply, download the RFA Overview. The application submission portal will open in June.